Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.64 +0.06 (+0.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Fennec Pharmaceuticals (FENC) Change in Other Operating Liabilities (2009 - 2025)

Updated

Analysis

Fennec Pharmaceuticals (FENC) Change in Other Operating Liabilities (2009 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.69 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -34.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -113.00 Mn
10 Fennec Pharmaceuticals 370.66 Mn 230.50 Mn 17.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -2,000.00
Sep 30, 2024 -437,000.00
Mar 31, 2024 25.25 Mn
Mar 31, 2012 35,000.00
Mar 31, 2010 35,000.00
Mar 31, 2009 35,000.00
API Access

Fennec Pharmaceuticals Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=FENC&period=max&api_key=YOUR_API_KEY